FT
Flare TherapeuticsFlare Therapeutics is a clinical-stage biotech developing small-molecule drugs that target transcription factors, including a first-in-class ARON-targeting degrader for prostate cancer.
2 Pulse stories
JN
Jupiter NeurosciencesClinical-stage biotech developing JOTROL, a proprietary high-bioavailability resveratrol platform targeting neuroinflammation, mitochondrial dysfunction, and longevity indications including Parkinson's and Alzheimer's disease.
1 Pulse story
Total Raised
$290M
Flare TherapeuticsJupiter Neurosciences
Last ValuationNot disclosed
Biotech
Sector
Biotech
2021
Founded
—
Cambridge, Massachusetts
HQ
Jupiter, Florida
Private
Status
Public (JUNS)
Flare Therapeutics investors
Third Rock VenturesNextech InvestPfizer VenturesBoxer CapitalGordonMD Global InvestmentsInvusCasdin CapitalEli Lilly and Company
Jupiter Neurosciences investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for Flare Therapeutics and Jupiter Neurosciences.